Published in J Cell Physiol on August 01, 2008
Polyomavirus BK and prostate cancer: an unworthy scientific effort? Oncoscience (2014) 0.83
RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis. Hepatology (2016) 0.78
Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses. Front Biol (Beijing) (2014) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol (1989) 8.68
G1 cell-cycle control and cancer. Nature (2004) 5.72
Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J (2002) 4.54
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene (2007) 3.67
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev (1997) 2.83
Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol (2001) 2.77
Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci U S A (1990) 2.76
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev (1997) 2.65
Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci U S A (1989) 2.64
Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1995) 2.43
HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science (1990) 2.23
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A (1995) 2.11
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene (1998) 1.78
Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene (2005) 1.64
The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene (1997) 1.58
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol (2005) 1.56
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
Apoptosis: mechanisms and relevance in cancer. Ann Hematol (2005) 1.44
Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene (1998) 1.40
The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem (2002) 1.39
Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol (2002) 1.34
The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J Biol Chem (2004) 1.34
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med (2000) 1.32
Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol (1998) 1.28
X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem (2000) 1.26
Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation. Mol Cell Biol (2000) 1.26
Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology (1996) 1.24
Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer (1999) 1.22
Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J Virol (1997) 1.22
Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res (2004) 1.21
Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Virology (1999) 1.20
Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. J Biol Chem (1998) 1.20
Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol (1996) 1.18
The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene (2005) 1.18
The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem (1998) 1.16
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J (2002) 1.14
Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter. J Virol (1997) 1.14
Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J Virol (1999) 1.11
HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1. Biochem J (2007) 1.05
Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis (2005) 1.04
Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB. Genes Cells (2006) 1.04
Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology (2006) 1.02
Human T-cell leukemia virus type 1 Tax attenuates gamma-irradiation-induced apoptosis through physical interaction with Chk2. Oncogene (2006) 1.01
Human T-cell leukemia virus type 1 Tax oncoprotein prevents DNA damage-induced chromatin egress of hyperphosphorylated Chk2. J Biol Chem (2007) 1.00
Ku protein as a potential human T-cell leukemia virus type 1 (HTLV-1) Tax target in clastogenic chromosomal instability of mammalian cells. Retrovirology (2005) 0.98
Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1. Oncogene (2004) 0.97
Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J Exp Med (1997) 0.96
Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res (2004) 0.96
The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein. Oncogene (2002) 0.95
Suppression of DNA repair by human T cell leukemia virus type 1 Tax is rescued by a functional p53 signaling pathway. J Biol Chem (2000) 0.95
The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose. Cell Death Differ (2005) 0.94
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood (2006) 0.94
Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. J Virol (1998) 0.93
Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity. Biochemistry (2003) 0.92
Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Res (1998) 0.91
Suppression of DNA repair by HTLV type 1 Tax correlates with Tax trans-activation of proliferating cell nuclear antigen gene expression. AIDS Res Hum Retroviruses (2000) 0.89
HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways. Int J Oncol (2006) 0.84
Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Pathol Int (2007) 0.82
HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology (2006) 1.87
Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene (2003) 1.19
Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology (2009) 1.16
Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response. J Virol (2008) 0.98
Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export. Retrovirology (2007) 0.97
The HTLV-I Tax oncoprotein: hyper-tasking at the molecular level. Front Biosci (2005) 0.95
Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax. Oncogene (2002) 0.91
Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors. Virology (2004) 0.90
Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism. J Virol (2006) 0.89
Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation. Environ Mol Mutagen (2005) 0.87
C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma. Viruses (2011) 0.87
Human T-cell leukemia virus type 1 Tax enhances serum response factor DNA binding and alters site selection. J Virol (2007) 0.82
Memories of John N. Brady: scientist, mentor and friend. Retrovirology (2009) 0.82
Meeting report on the 13th International Conference on Human Retrovirology: human T-cell leukemia virus research 30 years after adult T-cell leukemia. Cancer Res (2007) 0.81
The HTLV-1 Tax oncoprotein represses Ku80 gene expression. Virology (2011) 0.81
Identification of a functional serum response element in the HTLV-I LTR. Virology (2004) 0.79
Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage. PLoS One (2013) 0.79
Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1. J Virol (2007) 0.78
Human T-cell leukemia virus type 1 Tax relieves repression of proliferating cell nuclear antigen gene expression. J Virol (2008) 0.78
A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells. Virology (2005) 0.77
High throughput method to quantify anterior-posterior polarity of T-cells and epithelial cells. Viruses (2011) 0.75